Objective: Hepatocellular carcinoma (HCC) staging systems were developed using data predominantly from patients who had hepatitis and cirrhosis. Given the recent change in prevalence of viral hepatiti
Supplementary material. A. Conde-Ferreirós(*), L.A. Corchete (*), A. Jaka , Á. Santos-Briz,, MªJosé Fuente, R. Posada, Laura Pons, S. Podlipnik, R. M. Pujol, C. Román-Curto, A. Toll, J. Cañueto. PATTE
Protein predictors of poor outcomes in cutaneous squamous cell carcinoma. Tables including cell counts and tests used to perform hypothesis testing. STATA file includes dataset for meta-analysis.
